Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Princess Private Equity Holding ( (GB:PEY) ) has provided an announcement.
Partners Group Private Equity Limited has announced the sale of Clario, a leading provider of data collection and analysis solutions for drug developers, to Thermo Fisher Scientific. Clario, which was formed from the merger of eResearch Technology and BioClinica, has been instrumental in supporting numerous clinical trials and drug approvals. The sale aligns with PGPE Ltd’s strategy to realize value from its investments, with the transaction expected to close by the end of Q2 2026, pending regulatory approvals.
The most recent analyst rating on (GB:PEY) stock is a Sell with a EUR10.60 price target. To see the full list of analyst forecasts on Princess Private Equity Holding stock, see the GB:PEY Stock Forecast page.
More about Princess Private Equity Holding
Partners Group Private Equity Limited (PGPE Ltd) is an investment holding company founded in 1999 and based in Guernsey. It specializes in private equity direct investments and is managed by Partners Group, a global private markets investment management firm with over USD 174 billion in assets under management. PGPE Ltd aims to provide shareholders with long-term capital growth and an attractive dividend yield, and it is traded on the London Stock Exchange.
Average Trading Volume: 130,924
Technical Sentiment Signal: Strong Buy
For a thorough assessment of PEY stock, go to TipRanks’ Stock Analysis page.